CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

The year in cardiovascular medicine 2020: heart failure and cardiomyopathies Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis Risk of Mortality Following Catheter Ablation of Atrial Fibrillation Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial SPECT and PET in ischemic heart failure

Guideline2017 Aug 8;70(6):776-803

JOURNAL:J Am Coll Cardiol. Article Link

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Yancy CW, Jessup M, Bozkurt B et al. Keywords: ACC/AHA Clinical Practice Guidelines; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; ferric carboxymaltose; focused update; heart failure; hypertension; iron deficiency; ivabradine; natriuretic peptide biomarker; natriuretic peptides; sleep apnea

Full Text PDF